Diplomat Pharmacy (DPLO:NYSE) Investor Relations Material

Overview

Diplomat, a publicly traded company under NYSE ticker symbol DPLO, is a leading provider of medication management programs for patients with complex chronic diseases across the United States. Based in Flint, Michigan, the company caters to a range of serious or long-term conditions such as oncology, immunology, hepatitis, multiple sclerosis, infusion therapy, and more. With a commitment to supporting patients and physicians alike, Diplomat serves as a crucial player in the healthcare industry.

Frequently Asked Questions

What is Diplomat Pharmacy's ticker?

Diplomat Pharmacy's ticker is DPLO

What exchange is Diplomat Pharmacy traded on?

The company's shares trade on the NYSE stock exchange

Where are Diplomat Pharmacy's headquarters?

They are based in Flint, Michigan

How many employees does Diplomat Pharmacy have?

There are 1001-5000 employees working at Diplomat Pharmacy

What is Diplomat Pharmacy's website?

It is http://diplomat.is

What type of sector is Diplomat Pharmacy?

Diplomat Pharmacy is in the Healthcare sector

What type of industry is Diplomat Pharmacy?

Diplomat Pharmacy is in the Drugs - Generic industry

Who are Diplomat Pharmacy's peers and competitors?

The following five companies are Diplomat Pharmacy's industry peers:

- Sophiris Bio Inc.

- Tetraphase Pharma Inc

- Catalyst Pharmaceuticals

- Evoke Pharma Inc

- Biosyent